Lipur Pharmaceuticals Private Limited, a active private limited company, was established on 03 March 2017 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999BR2017PTC033873. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹9.50 M and a paid-up capital of ₹9.50 M.
It upholds a compliant status. Employing 4 professional, Its leadership includes Kavita Jha (Additional Director), Ritika (Director). Past directors included Rajkrishna Jha. It holds ₹8.90 M open charges and ₹6.25 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 105 B Luv Kush Appartment Lohiya Path, Jagdeo Path, Patna, Bihar, 800014.
U74999BR2017PTC033873
033873
03 March 2017
₹9.50 M
₹9.50 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Lipur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavita Jha | Additional Director | 08 Nov 2023 | Current |
| Ritika | Director | 03 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lipur Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.41% increase. The company also saw a substantial improvement in profitability, with a 44.12% increase in profit. The company's net worth moved up by a moderate rise of 2.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lipur Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹8,900,000.00
₹6,250,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jan 2025 | Others | ₹8.90 M | Open |
| 09 Dec 2023 | Others | ₹6.25 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lipur Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lipur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lipur Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 09 Dec 2023 via Charge ID 100830383 with Others was fully satisfied on 14 Jan 2025. was documented.
A charge with Others amounted to Rs. 8.90 M with Charge ID 101028844 was registered on 13 Jan 2025. was recorded as a recent event.
The activity Lipur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Lipur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was recorded as a recent event.
A charge with Others amounted to Rs. 6.25 M with Charge ID 100830383 was registered on 09 Dec 2023. was recorded as a recent event.
The activity Kavita Jha was appointed as a Additional Director was appointed as a Additional Director on 08 Nov 2023 & has been associated with this company since 2 years 25 days . was completed.
The CIN of Lipur Pharmaceuticals Private Limited is U74999BR2017PTC033873.
Lipur Pharmaceuticals Private Limited is headquartered at 105 B Luv Kush Appartment Lohiya Path, Jagdeo Path, Patna, Bihar, 800014.
Lipur Pharmaceuticals Private Limited was incorporated on 03 March 2017.
The current directors of Lipur Pharmaceuticals Private Limited are
The primary industry of Lipur Pharmaceuticals Private Limited is Trade.
Lipur Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lipur Pharmaceuticals Private Limited is ₹9.50 M, and the paid-up capital is ₹9.50 M.
The compliance status of Lipur Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX